TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Dividend Stocks
3 Growth Stocks You Can Bank On Being a Lot Bigger 10 Years From Now
Investing
Is the Cannabis Industry Getting Too Crowded?
Investing
Will “Aurora Sun” Heat Up Aurora Cannabis Inc. Stock This Summer?
Investing
Aphria Inc.’s Q3 Results Aren’t as Impressive as You May Think
Investing
Why the Long-term Marijuana Investor’s Thesis May Be Severely Flawed
Investing
Canadian Pot Stocks Get Hit Hard: Is it Time to Invest?
Investing
3 Things Investors Should Watch for in Aphria Inc.’s Q3 Results
Investing
Will Canadian Pot Stocks Still Beat the Market This Year?
Investing
Marijuana Legalization Is Coming! Why Canopy Growth Corp. Could Go Parabolic
Investing
Have Canadian Cannabis Stocks Reached Their Peak?